Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Grady Health System, Atlanta, Georgia Emory University Hospital Midtown, Atlanta, Georgia Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia Emory Saint Joseph's Hospital, Atlanta, Georgia Last updated January 2026